Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — A retrospective review of prospectively collected data presented here shows use of tranexamic acid ...

Patients with isolated severe traumatic brain injury (TBI) often receive prophylactic tranexamic acid before hospitalization to mitigate bleeding risk, but new results suggest the agent is linked to ...

Tranexamic Acid (T syl (500 mg)) is an antifibrinolytic agent, used for reduction or prevention of excessive menstrual bleeding. It is also used for prevention of bleeding due to other causes such as ...

WASHINGTON, DC—Administering tranexamic acid during noncardiac surgery provides a clear reduction in bleeding, with a low likelihood of harm in terms of vascular complications, the POISE-3 trial shows ...

For suspected severe traumatic brain injury (TBI), giving tranexamic acid to limit internal brain bleeding before trauma center arrival appeared safe -- except in those without evidence of ...

Please provide your email address to receive an email when new articles are posted on . More patients in the ED with hemoptysis saw an end to the condition with nebulized vs. IV tranexamic acid.

The use of tranexamic acid reduces mortality due to postpartum hemorrhage. We investigated whether the prophylactic administration of tranexamic acid in addition to prophylactic oxytocin in women with ...

A meta-analysis showed that the use of oral tranexamic acid along with the standard triple combination cream (TCC) reduces melasma severity and recurrence in patients with melasma, without increasing ...